miRNAs from Blood Serum as an Early Diagnostic Biomarker for Parkinson's Disease: A Study in an Animal Model

被引：0
|
作者：
Ahmad, M. D.
Dholaniya, P. S. D.
机构：
来源：
MOVEMENT DISORDERS | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1453
引用
收藏
页码：S637 / S637
页数：1
相关论文
共 50 条
  • [21] Diagnostic accuracy in early Parkinson's disease
    Rajput, AH
    Jankovic, J
    McDermott, M
    NEUROLOGY, 1997, 48 (03) : 60001 - 60001
  • [22] Diagnostic aspects of early Parkinson's disease
    Mueller, Thomas
    Fuchs, Gerd
    Hahne, Matthias
    Klein, Wolfgang
    Schwarz, Michael
    JOURNAL OF NEUROLOGY, 2006, 253 (Suppl 4) : 29 - 31
  • [23] The potential use of plasma NfL as a diagnostic and prognostic biomarker of fatigue in early Parkinson's disease
    Che, Ningning
    Huang, Jingxuan
    Wang, Shichan
    Jiang, Qirui
    Yang, Tianmi
    Xiao, Yi
    Lin, Junyu
    Fu, Jiajia
    Ou, Ruwei
    Li, Chunyu
    Chen, Xueping
    Shang, Huifang
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2025, 18
  • [24] Protein Binding Partners of Dysregulated miRNAs in Parkinson's Disease Serum
    Ruf, Wolfgang P.
    Freischmidt, Axel
    Grozdanov, Veselin
    Roth, Valerie
    Brockmann, Sarah J.
    Mollenhauer, Brit
    Martin, Dorothea
    Haslinger, Bernhard
    Fundel-Clemens, Katrin
    Otto, Markus
    von Arnim, Christine
    Holzmann, Karlheinz
    Ludolph, Albert C.
    Weishaupt, Jochen H.
    Danzer, Karin M.
    CELLS, 2021, 10 (04)
  • [25] Olfactory Dysfunction as an Early Biomarker in Parkinson's Disease
    Michelle E.Fullard
    James F.Morley
    John E.Duda
    Neuroscience Bulletin, 2017, 33 (05) : 515 - 525
  • [26] Olfactory Dysfunction as an Early Biomarker in Parkinson's Disease
    Fullard, Michelle E.
    Morley, James F.
    Duda, John E.
    NEUROSCIENCE BULLETIN, 2017, 33 (05) : 515 - 525
  • [27] Olfactory Dysfunction as an Early Biomarker in Parkinson’s Disease
    Michelle E. Fullard
    James F. Morley
    John E. Duda
    Neuroscience Bulletin, 2017, 33 : 515 - 525
  • [28] Early life exposure to permethrin: a progressive animal model of Parkinson's disease
    Nasuti, Cinzia
    Brunori, Gloria
    Eusepi, Piera
    Marinelli, Lisa
    Ciccocioppo, Roberto
    Gabbianelli, Rosita
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2017, 83 : 80 - 86
  • [29] Automated Neuromelanin Imaging as a Diagnostic Biomarker for Parkinson's Disease
    Castellanos, Gabriel
    Fernandez-Seara, Maria A.
    Lorenzo-Betancor, Oswaldo
    Ortega-Cubero, Sara
    Puigvert, Marc
    Uranga, Javier
    Vidorreta, Marta
    Irigoyen, Jaione
    Lorenzo, Elena
    Munoz-Barrutia, Arrate
    Ortiz-de-Solorzano, Carlos
    Pastor, Pau
    Pastor, Maria A.
    MOVEMENT DISORDERS, 2015, 30 (07) : 945 - 952
  • [30] Serum caffeine its metabolites are reliable diagnostic biomakers of early Parkinson's disease
    Motoki, F.
    Saiki, S.
    Yuanzhe, L.
    Naoko, K.
    Hikari, T.
    Taku, H.
    KeiIchi, I.
    Yutaka, O.
    Akio, M.
    Ayami, O.
    Takahiro, K.
    Shin-Ichi, U.
    Yoko, I.
    Takashi, U.
    Yoshiki, M.
    Manabu, F.
    Nobutaka, H.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 585 - 586
12345